Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents

Eur Respir J. 2014 Aug;44(2):523-7. doi: 10.1183/09031936.00214713. Epub 2014 May 2.

Authors

Caroline Beynat-Mouterde¹, Guillaume Beltramo¹, Guillaume Lezmi², Didier Pernet³, Clio Camus¹, Annlyse Fanton¹, Pascal Foucher¹, Vincent Cottin⁴, Philippe Bonniaud⁵

Affiliations

¹ Service de Pneumologie et Soins Intensifs Respiratoires, CHU Le Bocage, Dijon, France.
² Service de Pneumologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France.
³ Service de Pneumologie, CHU Jean Minjoz, Besançon, France.
⁴ Louis Pradel Hospital, Claude Bernard Lyon 1 University, Lyon, France.
⁵ Service de Pneumologie et Soins Intensifs Respiratoires, CHU Le Bocage, Dijon, France Faculté de Médecine et Pharmacie, Université de Bourgogne, Dijon, France INSERM U866, Dijon, France philippe.bonniaud@chu-dijon.fr.

PMID: 24791830
DOI: 10.1183/09031936.00214713

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Adrenal Cortex Hormones / therapeutic use
Adult
Alkylating Agents / chemistry
Antineoplastic Agents / adverse effects*
Antineoplastic Agents, Alkylating / adverse effects
Child, Preschool
Female
Fibrosis
Humans
Lung / drug effects*
Male
Neoplasms / complications
Neoplasms / drug therapy
Pleura / physiopathology
Pneumonia / diagnosis
Pneumonia / physiopathology
Pulmonary Fibrosis / complications
Pulmonary Fibrosis / physiopathology*

Substances

Adrenal Cortex Hormones
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating